CBD (Cannabidiol) and CBD (Cannabidiol) for Chronic pain
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
CBD (Cannabidiol)
A non-intoxicating cannabinoid with rock-solid epilepsy evidence and promising-but-unsettled anxiety and sleep data.
Grade B4 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
CBD (Cannabidiol) for Chronic pain
Evidence grade C — Unclear
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | CBD (Cannabidiol) | CBD (Cannabidiol) for Chronic pain |
|---|---|---|
| Chronic pain | Evidence grade CSmall effectmixedUnclear | Evidence grade CSmall effectmixedUnclear |
Graded only in CBD (Cannabidiol)
- Rare epilepsies (Rx) Large effectEvidence grade A
- Anxiety Moderate effectEvidence grade B
- Sleep Small effectEvidence grade C
Graded only in CBD (Cannabidiol) for Chronic pain
None — every outcome it grades is graded in both.
What each entry says about the other
- CBD (Cannabidiol) for Chronic pain’s entry · Goes with: Read the full CBD (Cannabidiol) monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.